Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Revue du rhumatisme
Volume 79, n° 2
page 180 (mars 2012)
Doi : 10.1016/j.rhum.2011.08.003
accepted : 3 August 2011

Effet dissocié du traitement par tocilizumab dans la spondylarthrite. Commentaires sur l’article de Wendling et al. : « Short-term effect of IL-6 inhibition in spondylarthritis  », Joint Bone Spine 2010;77:624–5

Sandrine Malochet-Guinamand , Martin Soubrier
Service de rhumatologie, CHU Gabriel-Montpied, 58, rue Montalembert, 63000 Clermont-Ferrand, France 

Auteur correspondant.

Mots clés : Spondylarthrite, Tocilizumab, Traitement

 Ne pas utiliser, pour citation, la référence française de cet article, mais la référence anglaise de Joint Bone Spine (doi:10.1016/j.jbspin.2011.09.002).

© 2011  Société Française de Rhumatologie@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline